[{"address1": "2223 Avenida de la Playa", "address2": "Suite 208", "city": "La Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "619 400 1170", "website": "https://www.gribio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. W. Marc Hertz Ph.D.", "age": 54, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 617224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vipin  Kumar Chaturvedi Ph.D.", "age": 65, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 419420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leanne M. Kelly", "age": 47, "title": "CFO & Corporate Secretary", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 469420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Albert  Agro Ph.d.", "age": 60, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 461099, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.03, "open": 2.04, "dayLow": 2.0107, "dayHigh": 2.13, "regularMarketPreviousClose": 2.03, "regularMarketOpen": 2.04, "regularMarketDayLow": 2.0107, "regularMarketDayHigh": 2.13, "payoutRatio": 0.0, "beta": -1.443, "trailingPE": 0.022577092, "forwardPE": -0.77946764, "volume": 82243, "regularMarketVolume": 82243, "averageVolume": 1205998, "averageVolume10days": 219280, "averageDailyVolume10Day": 219280, "bid": 2.01, "ask": 2.1, "bidSize": 3, "askSize": 3, "marketCap": 5156375, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 22.95, "allTimeHigh": 480807.6, "allTimeLow": 1.1, "fiftyDayAverage": 1.7874, "twoHundredDayAverage": 3.576725, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 130375, "profitMargins": 0.0, "floatShares": 2514827, "sharesOutstanding": 2515305, "sharesShort": 247643, "sharesShortPriorMonth": 473026, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.098500006, "heldPercentInsiders": 0.00018999999, "heldPercentInstitutions": 0.014570001, "shortRatio": 0.67, "shortPercentOfFloat": 0.098500006, "impliedSharesOutstanding": 2626821, "bookValue": 1.331, "priceToBook": 1.5401953, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -11919000, "trailingEps": 90.8, "forwardEps": -2.63, "lastSplitFactor": "1:17", "lastSplitDate": 1740355200, "enterpriseToEbitda": -0.013, "52WeekChange": -0.82161504, "SandP52WeekChange": 0.16625166, "quoteType": "EQUITY", "currentPrice": 2.05, "targetHighPrice": 35.0, "targetLowPrice": 10.0, "targetMeanPrice": 22.5, "targetMedianPrice": 22.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 5122000, "totalCashPerShare": 2.036, "ebitda": -10027000, "totalDebt": 96000, "quickRatio": 2.218, "currentRatio": 2.415, "debtToEquity": 2.89, "returnOnAssets": -0.98684, "returnOnEquity": -2.48924, "freeCashflow": -5767375, "operatingCashflow": -9169000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GRI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 90.8, "epsForward": -2.63, "epsCurrentYear": -5.86, "priceEpsCurrentYear": -0.34982935, "fiftyDayAverageChange": 0.26259995, "fiftyDayAverageChangePercent": 0.14691728, "twoHundredDayAverageChange": -1.526725, "twoHundredDayAverageChangePercent": -0.42685, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612967400000, "postMarketChangePercent": 5.85366, "postMarketPrice": 2.17, "postMarketChange": 0.12, "regularMarketChange": 0.02, "regularMarketDayRange": "2.0107 - 2.13", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1205998, "fiftyTwoWeekLowChange": 0.9499999, "fiftyTwoWeekLowChangePercent": 0.86363626, "fiftyTwoWeekRange": "1.1 - 22.95", "fiftyTwoWeekHighChange": -20.900002, "fiftyTwoWeekHighChangePercent": -0.9106754, "fiftyTwoWeekChangePercent": -82.16151, "shortName": "GRI Bio, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": 0.985221, "regularMarketPrice": 2.05, "exchange": "NCM", "messageBoardId": "finmb_136941170", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "GRI Bio, Inc.", "corporateActions": [], "postMarketTime": 1761350009, "regularMarketTime": 1761336001, "displayName": "GRI Bio", "trailingPegRatio": null, "__fetch_time": "2025-10-25"}]